These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 7752148)

  • 1. The structure of aggrecan and its turnover in cartilage.
    Hardingham TE; Fosang AJ
    J Rheumatol Suppl; 1995 Feb; 43():86-90. PubMed ID: 7752148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The structure, function and turnover of aggrecan, the large aggregating proteoglycan from cartilage.
    Hardingham TE; Fosang AJ; Dudhia J
    Eur J Clin Chem Clin Biochem; 1994 Apr; 32(4):249-57. PubMed ID: 8038265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aggrecan degradation in human cartilage. Evidence for both matrix metalloproteinase and aggrecanase activity in normal, osteoarthritic, and rheumatoid joints.
    Lark MW; Bayne EK; Flanagan J; Harper CF; Hoerrner LA; Hutchinson NI; Singer II; Donatelli SA; Weidner JR; Williams HR; Mumford RA; Lohmander LS
    J Clin Invest; 1997 Jul; 100(1):93-106. PubMed ID: 9202061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aggrecanase versus matrix metalloproteinases in the catabolism of the interglobular domain of aggrecan in vitro.
    Little CB; Flannery CR; Hughes CE; Mort JS; Roughley PJ; Dent C; Caterson B
    Biochem J; 1999 Nov; 344 Pt 1(Pt 1):61-8. PubMed ID: 10548534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure and function of aggrecan.
    Kiani C; Chen L; Wu YJ; Yee AJ; Yang BB
    Cell Res; 2002 Mar; 12(1):19-32. PubMed ID: 11942407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Catabolism of aggrecan by explant cultures of human articular cartilage in the presence of retinoic acid.
    Ilic MZ; Mok MT; Williamson OD; Campbell MA; Hughes CE; Handley CJ
    Arch Biochem Biophys; 1995 Sep; 322(1):22-30. PubMed ID: 7574678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coincubation of bovine synovial or capsular tissue with cartilage generates a soluble "Aggrecanase" activity.
    Vankemmelbeke MN; Ilic MZ; Handley CJ; Knight CG; Buttle DJ
    Biochem Biophys Res Commun; 1999 Feb; 255(3):686-91. PubMed ID: 10049771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of link protein concentration on articular cartilage proteoglycan aggregation.
    Tang LH; Buckwalter JA; Rosenberg LC
    J Orthop Res; 1996 Mar; 14(2):334-9. PubMed ID: 8648515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aggrecan is degraded by matrix metalloproteinases in human arthritis. Evidence that matrix metalloproteinase and aggrecanase activities can be independent.
    Fosang AJ; Last K; Maciewicz RA
    J Clin Invest; 1996 Nov; 98(10):2292-9. PubMed ID: 8941646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mature bovine articular cartilage contains abundant aggrecan that is C-terminally truncated at Ala719-Ala720, a site which is readily cleaved by m-calpain.
    Oshita H; Sandy JD; Suzuki K; Akaike A; Bai Y; Sasaki T; Shimizu K
    Biochem J; 2004 Aug; 382(Pt 1):253-9. PubMed ID: 15175011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathways of aggrecan processing in joint tissues. Implications for disease mechanism and monitoring.
    Sandy JD; Plaas AH; Koob TJ
    Acta Orthop Scand Suppl; 1995 Oct; 266():26-32. PubMed ID: 8553857
    [No Abstract]   [Full Text] [Related]  

  • 12. The interglobular domain of cartilage aggrecan is cleaved by hemorrhagic metalloproteinase HT-d (atrolysin C) at the matrix metalloproteinase and aggrecanase sites.
    Tortorella MD; Pratta MA; Fox JW; Arner EC
    J Biol Chem; 1998 Mar; 273(10):5846-50. PubMed ID: 9488721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pathobiology of focal lesion development in aging human articular cartilage and molecular matrix changes characteristic of osteoarthritis.
    Squires GR; Okouneff S; Ionescu M; Poole AR
    Arthritis Rheum; 2003 May; 48(5):1261-70. PubMed ID: 12746899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The release of aggrecan fragments into synovial fluid after joint injury and in osteoarthritis.
    Lohmander LS
    J Rheumatol Suppl; 1995 Feb; 43():75-7. PubMed ID: 7752145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cleavage site specificity of cathepsin K toward cartilage proteoglycans and protease complex formation.
    Hou WS; Li Z; Büttner FH; Bartnik E; Brömme D
    Biol Chem; 2003 Jun; 384(6):891-7. PubMed ID: 12887056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural differences between two populations of articular cartilage proteoglycan aggregates.
    Buckwalter JA; Pita JC; Muller FJ; Nessler J
    J Orthop Res; 1994 Jan; 12(1):144-8. PubMed ID: 8113937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The interglobular domain of cartilage aggrecan is cleaved by PUMP, gelatinases, and cathepsin B.
    Fosang AJ; Neame PJ; Last K; Hardingham TE; Murphy G; Hamilton JA
    J Biol Chem; 1992 Sep; 267(27):19470-4. PubMed ID: 1326552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Turnover of type II collagen and aggrecan in cartilage matrix at the onset of inflammatory arthritis in humans: relationship to mediators of systemic and local inflammation.
    Fraser A; Fearon U; Billinghurst RC; Ionescu M; Reece R; Barwick T; Emery P; Poole AR; Veale DJ
    Arthritis Rheum; 2003 Nov; 48(11):3085-95. PubMed ID: 14613270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aggrecan degradation in osteoarthritis and rheumatoid arthritis.
    Lark MW; Bayne EK; Lohmander LS
    Acta Orthop Scand Suppl; 1995 Oct; 266():92-7. PubMed ID: 8553869
    [No Abstract]   [Full Text] [Related]  

  • 20. [Cartilage proteoglycan aggregate: structure and function].
    Watanabe H
    Clin Calcium; 2004 Jul; 14(7):9-14. PubMed ID: 15577070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.